Search
Link between healthy growth in the womb and improved numeracy and literacy skills in early primary school.
The health of Australia's children depends on a firm national commitment to implement the comprehensive strategy outlined by the Preventative Health Taskforce.
For the first time, the Australian Early Development Index (AEDI) has been completed nationally, giving Australia a snapshot of young children's development.
New research findings from the world's largest study predicting children's late language emergence has revealed that parents are not to blame for late talking
A ground breaking study of WA 5-year olds has found that more than a quarter of the children have developmental difficulties that could have life-long impacts.
An early childhood researcher based at The Kids Research Institute Australia’s Adelaide office has been honoured at South Australia’s Science Excellence and Innovation Awards for her work revealing the link between screen time exposure and toddlers’ language development.
WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary of EPI, we sought to quantify the public health impact of vaccination globally since the programme's inception.
To explore parents' experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes, being followed in the Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study.
Physical literacy development in early childhood, viewed by many as the foundation for lifelong physical activity engagement, is significantly influenced by parents. Our aim was to explore parents' understanding of physical literacy and gain insight into their perspectives on physical literacy promotion.
PEGasparaginase is known to be a critical drug for treating pediatric acute lymphoblastic leukemia (ALL), however, there is insufficient evidence to determine the optimal dose for infants who are less than one year of age at diagnosis. This international study was conducted to identify the pharmacokinetics of PEGasparaginase in infants with newly diagnosed ALL and gather insight into the clearance and dosing of this population.